Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management. [electronic resource]
Producer: 20201116Description: 48-56 p. digitalISSN:- 1477-0970
- Adult
- Alemtuzumab -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Immunologic Factors -- administration & dosage
- Incidence
- Interferon beta-1a -- administration & dosage
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Purpura, Thrombocytopenic, Idiopathic -- drug therapy
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.